表紙
市場調查報告書
商品編碼
1027622

子宮內膜異位症治療的全球市場:各藥物類型,各治療類型,各最終用途,各地區的市場規模調查與預測(2021年∼2027年)

Global Endometriosis Treatment Market Size study, By Drug Type, By Treatment Type, By End-use, Analysis Regional Forecasts 2021-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

子宮內膜異位症治療的市場規模,2021年∼2027年的預測期間內將有成長的趨勢。

本報告提供子宮內膜異位症治療的世界市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,各藥物類型、治療類型、最終用途、地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 摘要整理

第2章 市場定義和範圍

第3章 市場動態

  • 市場影響分析(2019年∼2027年)

第4章 產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 各藥物類型

  • 市場概述
  • 效能:潛力分析
  • 市場規模預測:2018年∼2027年(10億美元單位)
  • 子區隔分析
    • 口服避孕藥
    • Progestins
    • NSAID
    • GnRH Analogues
    • LNR-IUD
    • 其他

第6章 各治療類型

  • 市場概述
  • 效能:潛力分析
  • 市場規模預測:2018年∼2027年(10億美元單位)
  • 子區隔分析
    • 荷爾蒙療法
    • 疼痛管理

第7章 各最終用途

  • 市場概述
  • 效能:潛力分析
  • 市場規模預測:2018年∼2027年(10億美元單位)
  • 子區隔分析
    • 醫院藥局
    • 零售藥局
    • 藥妝店
    • 電子商務

第8章 地區分析

  • 全球地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲的概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美的概述
    • 巴西
    • 墨西哥
  • 其他地區

第9章 競爭資訊

    • 最高市場策略
  • 企業簡介
    • Abbott Laboratories
    • AbbVie Inc.
    • Astellas Pharma Inc.
    • Astra ZenecaPLC
    • Bayer AG
    • Eli Lilly and Company
    • Ipsen
    • Meditrina Pharmaceuticals Private Limited
    • Myovant Sciences Ltd
    • Neurocrine Biosciences Inc.

第10章 調查流程

目錄

The global Endometriosis Treatment Market reached USD XXX Billion in 2020. The Global Endometriosis Treatment Market tends to grow by a CAGR of XX% in the 2021-2027 period.

When tissues that make up the lining of the uterus, grow outside of it, the disorder is called endometriosis. In Endometriosis, women face pain in the lower abdomen, cramps, and sometimes a high flow of blood. Endometriosis is divided into stages between level 1 (minimum or starting stage) to level 4 (severe or extreme stage). The established player has odds in their favor to lead the market and also expand their business portfolio by launching higher efficient and well-tested drugs into the market. One of the major trends that are driving this market is the awareness among women health and safety and governments investing into better treatment facilities and upgraded technologies used to reduce these diseases. Patient assistance programs are also spreading widely among various regions. However, limited availability of diagnostics is a major factor affecting this market negatively, but diagnostic facilities are expected to increase in the future. The ultrasound market is going to cover the largest market share, due to the upgradation in the technology and growing demand for diagnostic procedures. In 2018, Astellas Pharma announced the manufacturing of Opigolix drug that will be used for oral treatment of endometriosis.

The key regions covered in the global Endometriosis Treatment market are North America, Latin America, Europe, East Asia, South Asia-Pacific, and the Middle East & Africa. North America holds the largest market share, because of growing awareness about endometriosis treatment and the rate of incidences growing rapidly in that region. Due to higher population, growing market, and a large number of market players being present in the market, the Asia Pacific region is expected to grow in the future.

Major market players included in this report are:

Abbott Laboratories

AbbVie Inc.

Astellas Pharma Inc.

AstraZeneca PLC

Bayer AG

Eli Lilly and Company

Ipsen

Meditrina Pharmaceuticals Private Limited

Myovant Sciences Ltd

Neurocrine Biosciences Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:

Oral Contraceptives

Progestins

NSAIDs

GnRH Analogues

LNR-IUDs

Others

By Treatment Type:

Hormonal Therapy

Pain Management

By End-use:

Hospital Pharmacies

Retail Pharmacies

Drugstores

e-Commerce

By Region:

North America

The U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global Endometriosis Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Endometriosis Treatment Market, by Drug Type, 2019-2027 (USD Billion)
    • 1.2.2. Endometriosis Treatment Market, by Treatment Type, 2019-2027 (USD Billion)
    • 1.2.3. Endometriosis Treatment Market, by End-use, 2019-2027 (USD Billion)
    • 1.2.4. Global Endometriosis Treatment Market, by region, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Endometriosis Treatment Market Definition and Scope

  • 2.1. The objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Endometriosis Treatment Market Dynamics

  • 3.1. Global Endometriosis Treatment Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing awareness about women health and safety
      • 3.1.1.2. The surge in demand for patient assistance program
    • 3.1.2. Market Challenges
      • 3.1.2.1. Limited availability of diagnostics
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Vertical business development (product expansions)

Chapter 4. Global Endometriosis Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. The threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Endometriosis Treatment Market by Drug Type

  • 5.1. Market Snapshot
  • 5.2. Global Endometriosis Treatment Market by Drug Type, Performance - Potential Analysis
  • 5.3. Global Endometriosis Treatment Market estimates & Forecasts by Drug Type 2018-2027 (USD Billion)
  • 5.4. Endometriosis Treatment Market, Sub Segment Analysis
    • 5.4.1. Oral Contraceptives
    • 5.4.2. Progestins
    • 5.4.3. NSAIDs
    • 5.4.4. GnRH Analogues
    • 5.4.5. LNR-IUDs
    • 5.4.6. Others

Chapter 6. Global Endometriosis Treatment Market by Treatment Type

  • 6.1. Market Snapshot
  • 6.2. Global Endometriosis Treatment Market by Treatment Type, Performance - Potential Analysis
  • 6.3. Global Endometriosis Treatment Market estimates & Forecasts by Treatment Type 2018-2027 (USD Billion)
  • 6.4. Endometriosis Treatment Market, Sub Segment Analysis
    • 6.4.1. Hormonal Therapy
    • 6.4.2. Pain Management

Chapter 7. Global Endometriosis Treatment Market by End-use

  • 7.1. Market Snapshot
  • 7.2. Global Endometriosis Treatment Market by End-use, Performance - Potential Analysis
  • 7.3. Global Endometriosis Treatment Market estimates & Forecasts by End-use 2018-2027 (USD Billion)
  • 7.4. Endometriosis Treatment Market, Sub Segment Analysis
    • 7.4.1. Hospital Pharmacies
    • 7.4.2. Retail Pharmacies
    • 7.4.3. Drugstores
    • 7.4.4. e-Commerce

Chapter 8. Global Endometriosis Treatment Market, Regional Analysis

  • 8.1. Global Endometriosis Treatment Market, Regional Market Snapshot
  • 8.2. North America Endometriosis Treatment Market
    • 8.2.1. U.S. Endometriosis Treatment Market
      • 8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2027
      • 8.2.1.2. Treatment Type breakdown estimates & forecasts, 2018-2027
      • 8.2.1.3. End-use breakdown estimates & forecasts, 2018-2027
    • 8.2.2. Canada Endometriosis Treatment Market
  • 8.3. Europe Endometriosis Treatment Market Snapshot
    • 8.3.1. The U.K. Endometriosis Treatment Market
    • 8.3.2. Germany Endometriosis Treatment Market
    • 8.3.3. France Endometriosis Treatment Market
    • 8.3.4. Spain Endometriosis Treatment Market
    • 8.3.5. Italy Endometriosis Treatment Market
    • 8.3.6. Rest of Europe Endometriosis Treatment Market
  • 8.4. Asia-Pacific Endometriosis Treatment Market Snapshot
    • 8.4.1. China Endometriosis Treatment Market
    • 8.4.2. India Endometriosis Treatment Market
    • 8.4.3. Japan Endometriosis Treatment Market
    • 8.4.4. Australia Endometriosis Treatment Market
    • 8.4.5. South Korea Endometriosis Treatment Market
    • 8.4.6. Rest of Asia Pacific Endometriosis Treatment Market
  • 8.5. Latin America Endometriosis Treatment Market Snapshot
    • 8.5.1. Brazil Endometriosis Treatment Market
    • 8.5.2. Mexico Endometriosis Treatment Market
  • 8.6. Rest of The World Endometriosis Treatment Market

Chapter 9. Competitive Intelligence

    • 9.1.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Abbott Laboratories
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. AbbVie Inc.
    • 9.2.3. Astellas Pharma Inc.
    • 9.2.4. AstraZeneca PLC
    • 9.2.5. Bayer AG
    • 9.2.6. Eli Lilly and Company
    • 9.2.7. Ipsen
    • 9.2.8. Meditrina Pharmaceuticals Private Limited
    • 9.2.9. Myovant Sciences Ltd
    • 9.2.10. Neurocrine Biosciences Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Endometriosis Treatment Market, report scope
  • TABLE 2. Global Endometriosis Treatment Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 3. Global Endometriosis Treatment Market estimates & forecasts by Drug Type 2018-2027 (USD Billion)
  • TABLE 4. Global Endometriosis Treatment Market estimates & forecasts by Treatment Type 2018-2027 (USD Billion)
  • TABLE 5. Global Endometriosis Treatment Market estimates & forecasts by End-use 2018-2027 (USD Billion)
  • TABLE 6. Global Endometriosis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Endometriosis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Endometriosis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Endometriosis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Endometriosis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Endometriosis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Endometriosis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Endometriosis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Endometriosis Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Endometriosis Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. U.S. Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. U.S. Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 18. U.S. Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 19. Canada Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Canada Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 21. Canada Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 22. UK Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 23. UK Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. UK Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. Germany Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 26. Germany Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. Germany Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. RoE Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 29. RoE Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. RoE Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. China Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 32. China Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. China Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. India Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 35. India Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. India Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. Japan Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 38. Japan Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. Japan Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. RoAPAC Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 41. RoAPAC Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. RoAPAC Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. Brazil Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 44. Brazil Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. Brazil Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. Mexico Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 47. Mexico Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. Mexico Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. RoLA Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 50. RoLA Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. RoLA Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. Row Endometriosis Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 53. Row Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. Row Endometriosis Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of Endometriosis Treatment Market
  • TABLE 56. List of primary sources, used in the study of Endometriosis Treatment Market
  • TABLE 57. Years Considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Endometriosis Treatment Market, research methodology
  • FIG 2. Global Endometriosis Treatment Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Endometriosis Treatment Market, key trends 2020
  • FIG 5. Global Endometriosis Treatment Market, growth prospects 2021-2027
  • FIG 6. Global Endometriosis Treatment Market, porters 5 force model
  • FIG 7. Global Endometriosis Treatment Market, pest analysis
  • FIG 8. Global Endometriosis Treatment Market, value chain analysis
  • FIG 9. Global Endometriosis Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Endometriosis Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Endometriosis Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Endometriosis Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Endometriosis Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Endometriosis Treatment Market, regional snapshot 2018 & 2027
  • FIG 15. North America Endometriosis Treatment Market2018 & 2027 (USD Billion)
  • FIG 16. Europe Endometriosis Treatment Market2018 & 2027 (USD Billion)
  • FIG 17. Asia Pacific Endometriosis Treatment Market2018 & 2027 (USD Billion)
  • FIG 18. Latin America Endometriosis Treatment Market2018 & 2027 (USD Billion)
  • FIG 19. Global Endometriosis Treatment Market, company market share analysis (2020)